Learning Objectives:

  1. Magnetic resonance (CMR) volumetric quantification in risk stratification in patients with chronic
  2. moderate or severe AR
  3. Incremental value of cMRI over other imaging modalities in valvular heart disease in prognostic information
  4. To discuss the strengths and weakness of the evidence and it’s clinical application in our practice
Session date: 
08/19/2022 - 7:30am to 8:30am CDT
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Participation

Please login or create an account to proceed.
Speaker Name: 
Senthil S. Balasubramanian, MD